 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/01/2025 |
$24.74 |
$25.21 |
$24.59 |
$24.85 |
1.08M | | 12/02/2025 |
$25.24 |
$25.68 |
$24.87 |
$25.43 |
1.73M | | 12/03/2025 |
$25.51 |
$26.12 |
$25.29 |
$25.88 |
1.44M | | 12/04/2025 |
$25.57 |
$26.76 |
$25.40 |
$26.55 |
1.81M | | 12/05/2025 |
$26.75 |
$27.61 |
$26.74 |
$27.44 |
2.12M |
|
|
| Acadia Pharmaceuticals Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. | |
|
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on December 01, 2025, ACAD opened at $24.74, traded as high as $25.21 and as low as $24.59, and closed at $24.85. Trading volume was a total of 1.08M shares. On December 02, 2025, ACAD opened at $25.24, traded as high as $25.68 and as low as $24.87, and closed at $25.43. Trading volume was a total of 1.73M shares. On December 03, 2025, ACAD opened at $25.51, traded as high as $26.12 and as low as $25.29, and closed at $25.88. Trading volume was a total of 1.44M shares. On December 04, 2025, ACAD opened at $25.57, traded as high as $26.76 and as low as $25.40, and closed at $26.55. Trading volume was a total of 1.81M shares. On December 05, 2025, ACAD opened at $26.75, traded as high as $27.61 and as low as $26.74, and closed at $27.44. Trading volume was a total of 2.12M shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/09/2015 |
|
| End date: |
12/05/2025 |
|
| Start price/share: |
$34.29 |
|
| End price/share: |
$27.44 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-19.98% |
|
| Average Annual Total Return: |
-2.20% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,005.99 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 12/01/2025 | $24.85 | | 12/02/2025 | $25.43 | | 12/03/2025 | $25.88 | | 12/04/2025 | $26.55 | | 12/05/2025 | $27.44 |
|
|
Free ACAD Email Alerts:
